(800)525-7111 Free Consultation

Blog Archives

Who Made Zantac?

December 8, 2021   |  
Zantac was once one of the most popular heartburn medications on the market. However, after a probable human carcinogen, N-Nitrosodimethylamine (NDMA), was found in Zantac, it triggered a slew of Zantac lawsuits and a nationwide recall. Now, consumers have deep concerns about the safety of this product. Of course, the...
Read More

First Zantac Trial Scheduled in California

September 22, 2021   |  
Following a wave of consumer lawsuits against the makers of popular heartburn medication Zantac, a California state court judge has scheduled the first Zantac trial. The first Zantac “bellwether” trial is set to take place on October 10, 2022, in Oakland, California. First Zantac Bellwether Trial This is the first...
Read More

Court Rules Against Generic Zantac Lawsuits

July 28, 2021   |  
There is huge news in Zantac cancer lawsuits. In early July 2021, a federal court ruled against plaintiffs in generic Zantac lawsuits, saying that manufacturers of generic Zantac cannot face litigation alleging that their generic ranitidine causes cancer. The ruling affects thousands of lawsuits alleging that generic versions of Zantac...
Read More

Zantac MDL and Litigation Update: What’s Happening with Zantac Lawsuits?

December 9, 2020   |  
Zantac and ranitidine manufacturers face allegations that they ignored cancer risks associated with Zantac and ranitidine, and Zantac lawsuits are heating up. Thousands of claims alleging that Zantac causes cancer have been filed since an independent lab released an alarming report and the FDA issued its own Zantac warning. This...
Read More

What Potential Compensation is Available in a Zantac Lawsuit?

September 16, 2020   |  
As Zantac lawsuits heat up across the country, many are asking, “What compensation is available in Zantac cancer lawsuits?” Zantac, the brand name for the generic drug ranitidine, is contaminated with NDMA, which has been identified as a probable human carcinogen. It may have put thousands at risk for developing...
Read More

What Are the Symptoms of Cancer Caused by Zantac?

September 16, 2020   |  
If you’ve seen the news that Zantac can cause cancer due to NDMA contamination, you may be wondering, “What are the symptoms of cancers caused by Zantac?” It’s a difficult question because so many cancers are potentially linked to Zantac. In fact, at least 20 different types of cancer have...
Read More

“How Can I Prove My Cancer Was Caused by Zantac?”

September 10, 2020   |  
Zantac, the brand name for the generic drug ranitidine, contains NDMA, which the FDA has identified as a probable human carcinogen. Based on the most current research, taking Zantac may put you at risk for developing as many as 20 different types of cancers. Many of our Zantac lawsuit clients...
Read More

Does Zantac Cause Ovarian Cancer?

September 4, 2020   |  
In the wake of recent Zantac cancer claims, many are asking, “Does Zantac cause ovarian cancer?” Popular acid-blocking drug Zantac (brand name for the generic drug ranitidine) is now known to contain cancer-causing NDMA, and based on the most current scientific findings, Zantac may have put thousands of people at...
Read More

Zantac RICO Lawsuit and Potential Zantac Racketeering

September 3, 2020   |  
***UPDATE: The Federal District Court for the Southern District of Florida dismissed all RICO claims against all defendants in late June 2021. If you watch TV, you’ve likely seen Zantac commercials touting the merits of this supposed wonder drug. However, the truth about Zantac is now being revealed. A RICO lawsuit...
Read More

Zantac Investigation Launched by Department of Justice

August 6, 2020   |  
The Department of Justice has opened an investigation into Zantac manufacturers Sanofi and GlaxoSmithKline (GSK) in the wake of Food & Drug Administration (FDA) findings that the popular heartburn medication contains cancer-causing NDMA. The Justice Department's Zantac investigation is specifically focused on whether Sanofi and/or GSK violated the False Claims...
Read More